EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges

Joerg Klepper iD

Journal of Inherited Metabolic Disease · 2025-05 · 48 (3)

DOI: 10.1002/jimd.70044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 22.05.2025. Verfasst von Joerg Klepper. Beteiligte Einrichtung: Department of Pediatrics and Neuropediatrics, Childrens' Hospital Aschaffenburg, Aschaffenburg, Germany. Hauptthemen laut MEDLINE: Carbohydrate Metabolism, Inborn Errors, Monosaccharide Transport Proteins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glut1 Deficiency Syndrome (Glut1DS) has emerged as a treatable, but complex entity. Increasing data on pathogenic mechanisms, phenotype, genotype, and ketogenic dietary therapies (KDT) are available, as summarized in this review. Many challenges remain: novel symptoms emerge and vary with age. In Glut1DS, KDT in pregnancy and the clinical features in neonates and adults are poorly understood. KDT are ineffective in some patients for reasons yet unknown. Research reaches beyond the concept of brain energy depletion by impaired GLUT1‐mediated glucose transfer across the blood–brain barrier. Novel concepts investigate alternative substrates, transport mechanisms, and metabolic interactions of different brain cell types. Future, yet currently unavailable prospects are neonatal screening for Glut1DS, reliable biomarkers, predictors for outcome, and alternative therapies, along with and beyond KDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbohydrate Metabolism, Inborn ErrorsMonosaccharide Transport ProteinsHumansDiet, KetogenicGlucose Transporter Type 1Infant, NewbornPregnancyFemalePhenotypeGlucoseBlood-Brain BarrierBrain

Stichwörter der Autor:innen

De Vivo diseaseGLUT1Glut1 Deficiency SyndromeGlut1DSSLC2A1hypoglycorrhachiaketogenic dietary therapiestreatable

Substanzen

Monosaccharide Transport ProteinsGlucose Transporter Type 1GlucoseSLC2A1 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics and Neuropediatrics, Childrens' Hospital Aschaffenburg, Aschaffenburg, Germany.

ORCID-Profile: Joerg Klepper

Zitieren

APA

Klepper, J. (2025). Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges. Journal of Inherited Metabolic Disease, 48(3). https://doi.org/10.1002/jimd.70044

Vancouver

Klepper J. Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges. Journal of Inherited Metabolic Disease. 2025;48(3). doi:10.1002/jimd.70044

BibTeX
@article{Klepper2025,
  author = {Klepper, Joerg},
  title = {Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  volume = {48},
  number = {3},
  doi = {10.1002/jimd.70044}
}
Kostenlos starten →